Dyne Immune Institute for Translational Medicine and Research
A small research organization focused on rapid pathogen detection, ultra‑sensitive antigen assays, and translational efforts for prophylaxis and remediation of infectious disease. The institute develops point‑of‑care and automated laboratory screening formats for clinical, environmental, veterinary and defense applications and seeks R&D and licensing collaborations.
Industries
Nr. of Employees
small (1-50)
Dyne Immune Institute for Translational Medicine and Research
Hudson, New York, United States, North America
Products
Rapid early‑detection field assay and automated laboratory screening platform (under development)
A platform family including non‑instrument field assays for on‑site antemortem screening and automated laboratory equipment for high‑throughput pathogen screening; intended to provide faster turnaround than standard culture or instrument‑based PCR workflows.
Rapid early‑detection field assay and automated laboratory screening platform (under development)
A platform family including non‑instrument field assays for on‑site antemortem screening and automated laboratory equipment for high‑throughput pathogen screening; intended to provide faster turnaround than standard culture or instrument‑based PCR workflows.
Services
Rapid pathogen screening services (lab and field)
Provision of rapid screening assays in non‑instrument field kits and automated laboratory formats for clinical, environmental and veterinary pathogen surveillance.
Translational R&D for post‑exposure prophylaxis and medical countermeasures
Research and development programs focused on post‑exposure prophylaxis systems and prophylactic/vaccine technologies for public health and defense applications.
Rapid pathogen screening services (lab and field)
Provision of rapid screening assays in non‑instrument field kits and automated laboratory formats for clinical, environmental and veterinary pathogen surveillance.
Translational R&D for post‑exposure prophylaxis and medical countermeasures
Research and development programs focused on post‑exposure prophylaxis systems and prophylactic/vaccine technologies for public health and defense applications.
Expertise Areas
- Rapid pathogen detection and point‑of‑care assays
- Immunoassay development and ultra‑sensitive antigen detection
- Clinical screening workflows and infection control
- Environmental surveillance for nosocomial infection reduction
Key Technologies
- Immunoassays
- Photon‑counting detection methods
- Point‑of‑care non‑instrument test kits
- Automated high‑throughput laboratory screening platforms